“We're going to Assess how the commercialization of the substance matches in with our business enterprise design at Adastra in order to place ourselves to guidance the demand for a safe source of copyright,” stated Main executive officer Michael Forbes within a information release. The corporate told VICE News it wouldn't be commenting further.